Picture of Richter Gedeon Vegyeszeti Gyar Nyrt logo

RICHTER Richter Gedeon Vegyeszeti Gyar Nyrt News Story

0.000.00%
hu flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

Brief: Richter Says Pharma Revenues Grew By 11% YoY To HUF 237.5 Billion In Q2 2025

Aug 6 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU:

RICHTER: PHARMA REVENUES GREW BY 11% TO HUF 458BN IN H1 2025

RICHTER - FULL-YEAR GUIDANCE OF AROUND 10% INCREASE (EX-FX) IN BOTH REVENUES AND CLEAN EBIT IS MAINTAINED

RICHTER - PHARMA REVENUES GREW BY 11% YOY TO HUF 237.5BN IN Q2 2025

RICHTER - H1 2025 REVENUES TO HUF 458BN

RICHTER - NET PROFIT (ATTRIBUTABLE TO THE OWNERS OF THE PARENT) WAS HUF 120BN IN H1 2025

RICHTER - H1 2025 EBIT HUF 140.4BN

Source text: https://tinyurl.com/5n6cnb58

Further company coverage: GDRB.BU

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt

See all news